As US debates abortion pill ban, Argentina expands its use
By Anna-Catherine Brigida BUENOS AIRES (Reuters) – When Argentine trainee nursery teacher Lourdes, 24, went to the doctor in March…
Health
Colombia’s Grupo SURA nearly doubles profits in first quarter
(Reuters) – Net profit at Grupo SURA, Colombia’s largest investment company, almost doubled in the first quarter compared to the…
Abbott Labs is sued over PediaSure height claims
By Jonathan Stempel NEW YORK (Reuters) -A New York City woman sued Abbott Laboratories on Monday, accusing the healthcare company…
Natera wins $19 million US verdict from ArcherDX in cancer-detection patent case
By Blake Brittain (Reuters) – Genetic testing company Natera Inc convinced a Delaware federal jury on Monday to award it…
AI in Washington’s crosshairs but consensus far from certain
By Diane Bartz and Jeffrey Dastin WASHINGTON (Reuters) -U.S. lawmakers are grappling with what guardrails to put around burgeoning artificial…
Biden picks cancer surgeon Monica Bertagnolli to head NIH
By Julie Steenhuysen (Reuters) – The Biden administration on Monday said it intends to nominate cancer surgeon Dr. Monica Bertagnolli…
US Supreme Court rejects Teva challenge to $235 million GSK award in patent dispute
By Blake Brittain WASHINGTON (Reuters) – The U.S. Supreme Court on Monday declined to hear Teva Pharmaceuticals USA Inc’s challenge…
Sarepta surges after FDA panel backs Duchenne gene therapy
By Aditya Samal (Reuters) -Shares of Sarepta Therapeutics jumped 25% on Monday as a backing by the U.S. health regulator’s…
North Carolina governor vetoes 12-week abortion ban, override likely
By Julia Harte (Reuters) -North Carolina Democratic Governor Roy Cooper on Saturday vetoed a bill that would ban most abortions…
G7 plans new vaccine effort for developing nations, Yomiuri reports
TOKYO (Reuters) -The Group of Seven (G7) rich nations is set to agree on establishing a new programme to distribute…